OpenEvidence AI Scores Perfect 100% on USMLE
OpenEvidence has developed an AI system that scored a perfect 100% on the United States Medical Licensing Examination (USMLE), as announced in a press release.
Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
OpenEvidence has developed an AI system that scored a perfect 100% on the United States Medical Licensing Examination (USMLE), as announced in a press release.
Ryght AI has partnered with Biorasi to deliver AI-powered feasibility solutions to biotech and biopharma sponsors, announced in a press release. This collaboration aims to improve site selection and reduce trial delays.
MIT researchers have developed novel antibiotics using generative AI to combat drug-resistant bacteria, including MRSA and gonorrhea, as announced in a press release.
Inspiren has appointed Brian Geyser as Head of Clinical Innovation to enhance AI in senior care, announced in a press release. Geyser brings over 30 years of healthcare experience to the role.
Zifo has introduced its AI-powered Antibody Engineering application on the Snowflake Marketplace, designed to accelerate biologics and drug discovery by optimizing therapeutic antibodies.
Enlyte has launched the Medical Records Summarization (MRS) tool, combining AI and clinical expertise to streamline claims processing for auto injury adjusters.
AvodahMed and Pulse4Pulse have announced a collaboration to enhance preventative care using AI-driven screening solutions, as stated in a press release. The partnership aims to improve patient outcomes and streamline provider workflows.
RAAPID announced its participation in RISE West 2025, where it will launch its new AI-powered RADV Audit Solution, designed to enhance audit readiness for MA Health Plans.
Citizen Health has raised $30 million in Series A funding to develop an AI Advocate aimed at transforming patient-centered healthcare, announced in a press release.
Artera's AI-powered Flows Agents have facilitated 42 million unique patient sessions, with 94% of conversations completed without staff intervention, announced in a press release.
RIVANNA has received an $800,000 grant from the Virginia Catalyst Program to enhance its AI-enabled ultrasound platform for neuraxial anesthesia.
The Coalition for Health AI (CHAI) and the National Association of Community Health Centers (NACHC) have announced a strategic partnership to promote AI adoption in Community Health Centers across the U.S., according to a press release.
HopeAI showcased its AI-generated synthetic data at the ASCO 2025, promising to accelerate cancer drug trials by validating surrogate endpoints more efficiently.
Bizmatics has announced the launch of new AI tools designed to enhance clinical workflows and reduce documentation time for healthcare providers.
Ultrasound AI has published a study demonstrating its AI model's high accuracy in predicting delivery timing using ultrasound images, as announced in a press release.
HopeAI has joined the Mayo Clinic Platform Accelerate program to enhance drug development using AI, as announced in a press release. This partnership allows HopeAI to access Mayo Clinic's real-world data platform, aiming to improve clinical trial design and efficiency.
EasyPA has introduced an AI-powered platform to address inefficiencies in the prior authorization process, ahead of the 2026 CMS deadline.
Atlas Meditech's ATLAS AI has demonstrated superior diagnostic capabilities compared to clinicians and ChatGPT in a recent study, achieving a 90% success rate.
Medallion has been named to the 2025 Inc. 5000 list, highlighting its rapid growth in AI-powered provider network infrastructure.
Highmark Health and Abridge have announced a collaboration to deploy AI technologies across their healthcare ecosystem, focusing on enhancing patient-clinician interactions and streamlining prior authorization processes.